Sunesis Pharmaceuticals to Present at the Dawson James Securities 2nd Annual Small Cap Growth Stock Conference
18 October 2016 - 10:00PM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
Eric Bjerkholt, Chief Financial Officer of Sunesis, will present at
the Dawson James Securities 2nd Annual Small Cap Growth Stock
Conference on Thursday, October 20th at 9:30 AM Eastern Time at the
Wyndham Grand Hotel in Jupiter, Florida.
A live webcast of the presentation will be
available on the Sunesis website at http://ir.sunesis.com.
A replay of the webcast will be archived on the
"Calendar of Events" page in the Investors and Media section of the
Sunesis website for two weeks.
About Sunesis
PharmaceuticalsSunesis is a biopharmaceutical company
focused on the development and commercialization of new oncology
therapeutics for the potential treatment of solid and hematologic
cancers. Sunesis has built a highly experienced cancer drug
development organization committed to improving the lives of people
with cancer. Currently, the company is focused on pursuing
regulatory approval in Europe for its lead product candidate,
vosaroxin, for the treatment of relapsed or refractory acute
myeloid leukemia in patients aged 60 and older, as well as
advancing its novel kinase-inhibitor pipeline, which includes its
proprietary non-covalent BTK-inhibitor, SNS-062.
For additional information on Sunesis, please
visit http://www.sunesis.com.
SUNESIS and the logos are trademarks
of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More News Articles